Study of the role of Interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients

被引:2
作者
Shelbaya, S. [1 ]
Amer, H. [1 ]
Seddik, S. [1 ]
Allah, A. A. [1 ]
Sabry, I. M. [1 ]
Mohamed, T. [1 ]
El Mosely, M. [2 ]
机构
[1] Ain Shams Univ, Sch Med, Dept Internal Med, Endocrine Unit, Cairo, Egypt
[2] Ain Shams Univ, Sch Med, Dept Clin Pathol, Cairo, Egypt
关键词
Type; 1; DM; Diabetic nephropathy; Hs-CRP and IL6; ELEVATED LEVELS; YOUNG-ADULTS; RISK-FACTORS; INFLAMMATION; CHILDREN; MARKERS; MICROALBUMINURIA; ASSOCIATION; CHOLESTEROL; MELLITUS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Diabetes Mellitus (DM) is becoming an increasingly common disease which is the leading cause of chronic renal failure. The pathogenesis of diabetic nephropathy is still a matter of debate. There are conflicting results regarding the relation of C reactive protein (CRP), interleukin-6 (IL-6) and diabetic nephropathy in type 1 diabetes. Objectives: This study was aiming to determine the association between higly sensitive (Hs)-CRP and IL6 with nephropathy in a sample of type 1 diabetic Egyptian patients. Materials and Methods: The study was conducted on forty type-1 diabetic patients (Group l), who subdivided into three subgroups according to their urine albumin excretion rate (AER); Group IA: 10 patients with AER <20 mu g/min, Group IB: 15 patients with AER ranges from 20-200 mu g/min. Group IC: 15 patients with AER is >200 mu g/min and 10 healthy subjects as a control (Group II). Results: There were high statistical significant difference (p < 0.001) between group I with group II regarding HsCRP (4.39 +/- 1.94, 1.32 +/- 0.39), and IL-6 (2.82 +/- 0.76, 1.95 +/- 0.35). In group I, we found a positive significant correlation (p < 0.001) between UAE and levels of Hs-CRP (r = 0.927), and IL-6 (r = 0.838), respectively. Also, a positive significant correlation between Hs-CRP and IL-6 (r = 0.728, p < 0.001) was found. Fasting plasma glucose (FPG) level and HbA1c showed a significant positive correlation (p < 0.001) with Hs-CRP (r = 0.531) (r = 0.750), and IL-6 (r = 0.490) (r = 0.680) respectively. Conclusion: Hs-CRP and IL-6 are sensitive markers for diabetic nephropathy predicting its progression and severity in type 1 diabetics.
引用
收藏
页码:176 / 182
页数:7
相关论文
共 36 条
[1]   Cytokine secretion in long-standing diabetes mellitus type 1 and 2: Associations with low-grade systemic inflammation [J].
Alexandraki, Krystallenia I. ;
Piperi, Christina ;
Ziakas, Panayiotis D. ;
Apostolopoulos, Nikolaos V. ;
Makrilakis, Konstantinos ;
Syriou, Vassiliki ;
Diamanti-Kandarakis, Evanthia ;
Kaltsas, Gregory ;
Kalofoutis, Anastasios .
JOURNAL OF CLINICAL IMMUNOLOGY, 2008, 28 (04) :314-321
[2]   The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study [J].
Amin, R ;
Turner, C ;
van Aken, S ;
Bahu, TK ;
Watts, A ;
Lindsell, DRM ;
Dalton, RN ;
Dunger, DB .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1740-1749
[3]  
[Anonymous], CECIL MED
[4]  
[Anonymous], 2004, DIABETES CARE, V27, pS79, DOI DOI 10.2337/DIACARE.27.5.1240-A
[5]  
Choudhary Nikhil, 2008, Iran J Kidney Dis, V2, P72
[6]   Increase in C-reactive protein plasma levels during diabetes in infants and young adults [J].
Coulon, J ;
Willems, D ;
Dorcby, H .
PRESSE MEDICALE, 2005, 34 (02) :89-93
[7]   Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty [J].
Di Cesare, PE ;
Chang, E ;
Preston, CF ;
Liu, CJ .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (09) :1921-1927
[8]  
DOETSCH K, 1974, CLIN CHEM, V20, P1384
[9]   Serum IL-1β, IL-2, and IL-6 in insulin-dependent diabetic children [J].
Dogan, Yasar ;
Akarsu, Saadet ;
Ustundag, Bilal ;
Yilmaz, Erdal ;
Gurgoze, Metin Kaya .
MEDIATORS OF INFLAMMATION, 2006, 2006
[10]   Mediators of inflammation in children with type I diabetes mellitus:: cytokines in type I diabetic children [J].
Erbagci, AB ;
Tarakçioglu, M ;
Coskun, Y ;
Sivasli, E ;
Namiduru, ES .
CLINICAL BIOCHEMISTRY, 2001, 34 (08) :645-650